Advances in Understanding Long COVID: Pathophysiological Mechanisms and the Role of Omics Technologies in Biomarker Identification
Molecular Diagnosis & Therapy · 2025-09 · 29 (5) · 617-636
DOI: 10.1007/s40291-025-00792-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Diagnosis & Therapy, online erschienen am 18.06.2025. Verfasst von Mônica Duarte da Silva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, USA. Hauptthemen laut MEDLINE: COVID-19, Biomarkers, SARS-CoV-2. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Universidade de Lisboa.
Abstract (Originalsprache)
Long coronavirus disease (COVID) is a multisystem condition that affects a significant proportion of individuals following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with persistent symptoms ranging from fatigue and cognitive dysfunction to cardiovascular disorders. It is estimated that 30-60% of infected individuals experience symptoms lasting more than 12 weeks. Despite advances in understanding acute infection, the pathophysiological mechanisms underlying long COVID remain unclear. Current hypotheses suggest that viral persistence, immune dysfunction, and metabolic alterations play central roles. Omics approaches, including metabolomics, proteomics, and lipidomics, have played a crucial role in investigating molecular changes, identifying biomarkers, and refining therapeutic strategies. This review discusses recent advances in understanding long COVID, addressing its mechanisms, risk factors, the impact of viral variants, and the role of vaccination, with an emphasis on the importance of omics technologies in elucidating this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, USA.
- Graduate Program in Anatomy of Domestic and Wild Animals, Faculty of Veterinary Medicine and Animal Science, University of São Paulo (FMVZ/USP), São Paulo, Brazil.
- Department of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília, São Paulo, Brazil.
- Postgraduate Program in Structural and Functional Interactions in Rehabilitation, School of Medicine, Universidade de Marília (UNIMAR), Marília, São Paulo, Brazil.
- Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines, Universidade de Lisboa (iMed.ULisboa), Lisbon, Portugal. rdireito@ff.ulisboa.pt.
- Postgraduate Program in Animal Health, Production and Environment, School of Veterinary Medicine, Universidade de Marília (UNIMAR), Marília, São Paulo, Brazil.
ORCID-Profile: Rosa Direito
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Universidade de Lisboa
Zitieren
APA
da Silva, M. D., da Silva, T. S., Mendes, C. G., Valbão, M. C. M., Badu-Tawiah, A. K., Laurindo, L. F., Barbalho, S. M., Direito, R., & Miglino, M. A. (2025). Advances in Understanding Long COVID: Pathophysiological Mechanisms and the Role of Omics Technologies in Biomarker Identification. Molecular Diagnosis & Therapy, 29(5), 617-636. https://doi.org/10.1007/s40291-025-00792-8
Vancouver
da Silva MD, da Silva TS, Mendes CG, Valbão MCM, Badu-Tawiah AK, Laurindo LF, et al. Advances in Understanding Long COVID: Pathophysiological Mechanisms and the Role of Omics Technologies in Biomarker Identification. Molecular Diagnosis & Therapy. 2025;29(5):617-636. doi:10.1007/s40291-025-00792-8
BibTeX
@article{daSilva2025,
author = {da Silva, Mônica Duarte and da Silva, Thamires Santos and Mendes, Claudemir Gregório and Valbão, Maria Carolina Miglino and Badu-Tawiah, Abraham Kwame and Laurindo, Lucas Fornari and Barbalho, Sandra Maria and Direito, Rosa and Miglino, Maria Angélica},
title = {Advances in Understanding Long COVID: Pathophysiological Mechanisms and the Role of Omics Technologies in Biomarker Identification},
journal = {Molecular Diagnosis & Therapy},
year = {2025},
volume = {29},
number = {5},
pages = {617--636},
doi = {10.1007/s40291-025-00792-8}
}
EUVIMED